Anatara Lifesciences (ASX:ANR) Marketable Securities : A$0.05 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Anatara Lifesciences Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Anatara Lifesciences's Marketable Securities for the quarter that ended in Dec. 2023 was A$0.05 Mil.

Anatara Lifesciences's annual Marketable Securities increased from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.05 Mil) but then stayed the same from Jun. 2022 (A$0.05 Mil) to Jun. 2023 (A$0.05 Mil).

Anatara Lifesciences Marketable Securities Historical Data

The historical data trend for Anatara Lifesciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatara Lifesciences Marketable Securities Chart

Anatara Lifesciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Marketable Securities

Get a 7-Day Free Trial

4.05

0.05

Anatara Lifesciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Marketable Securities	Get a 7-Day Free Trial														-	0.05	-	0.05	0.05

Anatara Lifesciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Anatara Lifesciences (ASX:ANR) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Anatara Lifesciences Marketable Securities Related Terms

Thank you for viewing the detailed overview of Anatara Lifesciences's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Anatara Lifesciences (ASX:ANR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anatara Lifesciences Ltd (ASX:ANR) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Perks, 81 Flinders Street, Level 8, Adelaide, SA, AUS, 5000

Website

https://www.anataralifesciences.com

Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.

Anatara Lifesciences (ASX:ANR) Headlines

No Headlines